KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Takeda Pharmaceutical (TAK) Cash & Current Investments (2018 - 2026)

Takeda Pharmaceutical has reported Cash & Current Investments over the past 9 years, most recently at $6.6 billion for Q1 2026.

  • For Q1 2026, Cash & Current Investments rose 36.76% year-over-year to $6.6 billion; the TTM value through Mar 2026 reached $6.6 billion, up 36.76%, while the annual FY2026 figure was $6.9 billion, 42.26% up from the prior year.
  • Cash & Current Investments was $6.6 billion for Q1 2026 at Takeda Pharmaceutical, up from $4.8 billion in the prior quarter.
  • Across five years, Cash & Current Investments topped out at $7.5 billion in Q1 2022 and bottomed at $3.2 billion in Q1 2024.
  • The 5-year median for Cash & Current Investments is $4.8 billion (2025), against an average of $5.3 billion.
  • Year-over-year, Cash & Current Investments plummeted 44.4% in 2023 and then skyrocketed 51.23% in 2025.
  • Over 5 years, Cash & Current Investments stood at $7.5 billion in 2022, then crashed by 44.4% to $4.2 billion in 2023, then fell by 23.77% to $3.2 billion in 2024, then skyrocketed by 51.23% to $4.8 billion in 2025, then skyrocketed by 36.76% to $6.6 billion in 2026.
  • The last three reported values for Cash & Current Investments were $6.6 billion (Q1 2026), $4.8 billion (Q1 2025), and $3.2 billion (Q1 2024) per Business Quant data.